| Cancer-related molecular mechanisms research | Lifetime | 42 | JP 2 | 99.71 |
| Metastasis and carcinoma case studies | Lifetime | 16 | JP 10 | 99.63 |
| Gastric Cancer Management and Outcomes | Lifetime | 79 | JP 19 | 99.71 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 47 | JP 11 | 99.62 |
| Cancer-related gene regulation | Lifetime | 65 | JP 6 | 99.44 |
| Esophageal Cancer Research and Treatment | Lifetime | 64 | JP 9 | 99.44 |
| MicroRNA in disease regulation | Lifetime | 162 | JP 8 | 99.27 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 106 | JP 21 | 99.35 |
| Genetic factors in colorectal cancer | Lifetime | 120 | JP 2 | 99.37 |
| Cancer Research and Treatments | Lifetime | 143 | JP 3 | 98.94 |
| Epigenetics and DNA Methylation | Lifetime | 291 | JP 14 | 99.15 |
| Peptidase Inhibition and Analysis | Lifetime | 209 | JP 9 | 99.07 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 329 | JP 10 | 99.02 |
| Cancer Cells and Metastasis | Lifetime | 206 | JP 7 | 98.94 |
| RNA modifications and cancer | Lifetime | 759 | JP 41 | 98.56 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 441 | JP 42 | 98.78 |
| Esophageal and GI Pathology | Lifetime | 498 | JP 42 | 98.26 |
| Lung Cancer Treatments and Mutations | Lifetime | 741 | JP 70 | 98.47 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 777 | JP 99 | 98.31 |
| Colorectal Cancer Treatments and Studies | Lifetime | 565 | JP 42 | 98.37 |
| Glycosylation and Glycoproteins Research | Lifetime | 894 | JP 54 | 97.66 |
| Cancer, Lipids, and Metabolism | Lifetime | 584 | JP 20 | 97.87 |
| Histone Deacetylase Inhibitors Research | Lifetime | 307 | JP 6 | 97.02 |
| Cancer Diagnosis and Treatment | Lifetime | 744 | JP 38 | 96.58 |
| Gastrointestinal disorders and treatments | Lifetime | 768 | JP 106 | 97.17 |
| Colorectal and Anal Carcinomas | Lifetime | 535 | JP 37 | 96.90 |
| Circular RNAs in diseases | Lifetime | 714 | JP 27 | 96.12 |
| Kruppel-like factors research | Lifetime | 205 | JP 15 | 95.73 |
| Cancer Mechanisms and Therapy | Lifetime | 427 | JP 28 | 95.75 |
| Protease and Inhibitor Mechanisms | Lifetime | 955 | JP 48 | 95.16 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 424 | JP 31 | 92.76 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 950 | JP 149 | 88.48 |
| Caveolin-1 and cellular processes | Lifetime | 428 | JP 28 | 90.06 |
| Chromatin Remodeling and Cancer | Lifetime | 654 | JP 39 | 87.02 |
| Minimally Invasive Surgical Techniques | Lifetime | 727 | JP 35 | 88.19 |
| FOXO transcription factor regulation | Lifetime | 797 | JP 55 | 76.53 |
| Mechanisms of cancer metastasis | Lifetime | 715 | JP 80 | 65.10 |
| Clusterin in disease pathology | Lifetime | 672 | JP 49 | 54.34 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 835 | JP 130 | 89.11 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 934 | JP 199 | 87.33 |
| Surgical Simulation and Training | 2021-2025 | 578 | JP 28 | 85.08 |
